Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 21, 2023; 29(27): 4334-4343
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4334
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4334
Group or subgroup | Events | Rate per 10 person-yr (95%CI) | HR (95%CI) | Adjusted HR (95%CI) |
Entire population | 141 | 1.4 (1.2-1.7) | ||
UC | 64 | 1.4 (1.1-1.7) | 1 | |
CD | 77 | 1.5 (1.2-1.8) | 1.16 (0.8-1.6) | |
Males | 85 | 1.7 (1.4-2.1) | 1 | |
Females | 56 | 1.2 (0.9-1.5) | 0.76 (0.5-1.1) | |
Age ≤ 35 yr | 62 | 1.9 (1.4-2.4) | 1 | |
Age > 35 yr | 79 | 1.2 (0.9-1.5) | 0.69 (0.5-0.9) | |
Active patients | 66 | 7.0 (5.5-8.9) | 1 | 1 |
Patients in remission | 21 | 0.7 (0.4-1.0) | 0.17 (0.1-0.3) | 0.17 (0.1-0.3) |
Other groups | 54 | 0.9 (0.7-1.2) | 0.25 (0.2-0.4) | 0.26 (0.1-0.4) |
- Citation: Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343
- URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4334